药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brinzolamide
Tenamfetamine
Tenamfetamine may decrease the sedative and stimulatory activities of Mepyramine.
Brinzolamide
4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative and stimulatory activities of Mepyramine.
Brinzolamide
2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative and stimulatory activities of Mepyramine.
Brinzolamide
MMDA
MMDA may decrease the sedative and stimulatory activities of Mepyramine.
Brinzolamide
Mephentermine
Mephentermine may decrease the sedative and stimulatory activities of Mepyramine.
Brinzolamide
Levomilnacipran
The risk or severity of adverse effects can be increased when Mepyramine is combined with Levomilnacipran.
Brinzolamide
Dapoxetine
The risk or severity of adverse effects can be increased when Mepyramine is combined with Dapoxetine.
Brinzolamide
Alaproclate
The risk or severity of adverse effects can be increased when Mepyramine is combined with Alaproclate.
Brinzolamide
Ritanserin
The risk or severity of adverse effects can be increased when Mepyramine is combined with Ritanserin.
Brinzolamide
Indalpine
The risk or severity of adverse effects can be increased when Mepyramine is combined with Indalpine.
Brinzolamide
Seproxetine
The risk or severity of adverse effects can be increased when Mepyramine is combined with Seproxetine.
Brinzolamide
Desvenlafaxine
The risk or severity of adverse effects can be increased when Mepyramine is combined with Desvenlafaxine.
Brinzolamide
Milnacipran
The risk or severity of adverse effects can be increased when Mepyramine is combined with Milnacipran.
Brinzolamide
Sodium oxybate
Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Brinzolamide
Betahistine
The therapeutic efficacy of Betahistine can be decreased when used in combination with Mepyramine.
Brinzolamide
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Mepyramine.
Brinzolamide
Suvorexant
Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Brinzolamide
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Mepyramine.
Brinzolamide
Rotigotine
Mepyramine may increase the sedative activities of Rotigotine.
Brinzolamide
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Mepyramine.